256 related articles for article (PubMed ID: 20585113)
1. Different classes of antibiotics differentially influence shiga toxin production.
McGannon CM; Fuller CA; Weiss AA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3790-8. PubMed ID: 20585113
[TBL] [Abstract][Full Text] [Related]
2. Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.
Shaikh N; Tarr PI
J Bacteriol; 2003 Jun; 185(12):3596-605. PubMed ID: 12775697
[TBL] [Abstract][Full Text] [Related]
3. Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.
Sheng L; Rasco B; Zhu MJ
Appl Environ Microbiol; 2016 Nov; 82(22):6531-6540. PubMed ID: 27590808
[TBL] [Abstract][Full Text] [Related]
4. Toxigenic properties and stx phage characterization of Escherichia coli O157 isolated from animal sources in a developing country setting.
Rahman M; Nabi A; Asadulghani M; Faruque SM; Islam MA
BMC Microbiol; 2018 Aug; 18(1):98. PubMed ID: 30170562
[TBL] [Abstract][Full Text] [Related]
5. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
Grif K; Dierich MP; Karch H; Allerberger F
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli O157:H7 strains harbor at least three distinct sequence types of Shiga toxin 2a-converting phages.
Yin S; Rusconi B; Sanjar F; Goswami K; Xiaoli L; Eppinger M; Dudley EG
BMC Genomics; 2015 Sep; 16():733. PubMed ID: 26416807
[TBL] [Abstract][Full Text] [Related]
7. Carriage of Shiga toxin phage profoundly affects Escherichia coli gene expression and carbon source utilization.
Berger P; Kouzel IU; Berger M; Haarmann N; Dobrindt U; Koudelka GB; Mellmann A
BMC Genomics; 2019 Jun; 20(1):504. PubMed ID: 31208335
[TBL] [Abstract][Full Text] [Related]
8. One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage.
Teel LD; Melton-Celsa AR; Schmitt CK; O'Brien AD
Infect Immun; 2002 Aug; 70(8):4282-91. PubMed ID: 12117937
[TBL] [Abstract][Full Text] [Related]
9. Cumulative effect of prophage burden on Shiga toxin production in Escherichia coli.
Fogg PCM; Saunders JR; McCarthy AJ; Allison HE
Microbiology (Reading); 2012 Feb; 158(Pt 2):488-497. PubMed ID: 22096150
[TBL] [Abstract][Full Text] [Related]
10. Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle.
Muniesa M; Blanco JE; de Simón M; Serra-Moreno R; Blanch AR; Jofre J
Microbiology (Reading); 2004 Sep; 150(Pt 9):2959-2971. PubMed ID: 15347754
[TBL] [Abstract][Full Text] [Related]
11. Bacteriophage 2851 is a prototype phage for dissemination of the Shiga toxin variant gene 2c in Escherichia coli O157:H7.
Strauch E; Hammerl JA; Konietzny A; Schneiker-Bekel S; Arnold W; Goesmann A; Pühler A; Beutin L
Infect Immun; 2008 Dec; 76(12):5466-77. PubMed ID: 18824528
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
Ochoa TJ; Chen J; Walker CM; Gonzales E; Cleary TG
Antimicrob Agents Chemother; 2007 Aug; 51(8):2837-41. PubMed ID: 17526759
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli serotype O55:H7 diversity supports parallel acquisition of bacteriophage at Shiga toxin phage insertion sites during evolution of the O157:H7 lineage.
Kyle JL; Cummings CA; Parker CT; Quiñones B; Vatta P; Newton E; Huynh S; Swimley M; Degoricija L; Barker M; Fontanoz S; Nguyen K; Patel R; Fang R; Tebbs R; Petrauskene O; Furtado M; Mandrell RE
J Bacteriol; 2012 Apr; 194(8):1885-96. PubMed ID: 22328665
[TBL] [Abstract][Full Text] [Related]
14. Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection.
Zhang Q; Donohue-Rolfe A; Krautz-Peterson G; Sevo M; Parry N; Abeijon C; Tzipori S
J Infect Dis; 2009 Feb; 199(4):486-93. PubMed ID: 19125676
[TBL] [Abstract][Full Text] [Related]
15. First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.
Strauch E; Schaudinn C; Beutin L
Infect Immun; 2004 Dec; 72(12):7030-9. PubMed ID: 15557626
[TBL] [Abstract][Full Text] [Related]
16. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.
Bielaszewska M; Idelevich EA; Zhang W; Bauwens A; Schaumburg F; Mellmann A; Peters G; Karch H
Antimicrob Agents Chemother; 2012 Jun; 56(6):3277-82. PubMed ID: 22391549
[TBL] [Abstract][Full Text] [Related]
17. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
[TBL] [Abstract][Full Text] [Related]
18. Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.
Gamage SD; Patton AK; Strasser JE; Chalk CL; Weiss AA
Infect Immun; 2006 Mar; 74(3):1977-83. PubMed ID: 16495578
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
[TBL] [Abstract][Full Text] [Related]
20. Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
Nassar FJ; Rahal EA; Sabra A; Matar GM
Foodborne Pathog Dis; 2013 Sep; 10(9):805-12. PubMed ID: 23808851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
